Asthma Drug Montelukast Tested as Alzheimer’s Treatment in Proof-of-concept Trial

Asthma Drug Montelukast Tested as Alzheimer’s Treatment in Proof-of-concept Trial
Canada’s IntelGenx has launched a Phase 2a proof-of-concept trial to explore whether the old asthma medication montelukast may be an option for treating Alzheimer’s disease. The idea that montelukast — also used to treat hay fever — may succeed where other approaches have failed, stems from research at Austria’s Paracelsus Medical University in Salzburg. A team led

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

  1. Very interesting indeed. A drug used for asthma and hay fever may treat Alzheimer’s disease! We just have to keep our fingers crossed for the next 26 weeks to see how this proof-of-concept trial turns out.

  2. Joanna Crowder says:

    I thought I should share my personal experience. It made me so forgetful I thought I was developing Alzheimer’s. Within 24 hours after I stopped taking it I noticed a significant improvement. It has been three weeks now and I continue to improve. I am 65 and female . I have not seen much anecdotal evidence that this is common in adults but it was so very apparent in my life I thought I should share. Please check your parents because this was real and very noticeable by my friends and family as well.

Leave a Comment

Your email address will not be published. Required fields are marked *